Business Standard

Thursday, December 26, 2024 | 03:50 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's falls on buzz of issues raised in EIR for Duvvada plant

The stock dipped 4.5% to Rs 2,299 on the BSE in intra-day trade.

reddy, dr reddy's
Premium

Dr Reddy's laboratory

SI Reporter Mumbai
Dr Reddy’s Laboratories dipped 4.5% to Rs 2,299 on the BSE in intra-day trade after media reports suggested that the US Food and Drug Administration (USFDA) issues raised in Establishment Inspection Report (EIR) for the company's injectables unit in Duvvada, Andhra Pradesh.

The BSE said the exchange has sought clarification from Dr Reddy’s Laboratories on January 03, 2018 with reference to news flashed on www.moneycontrol.com dated January 03, 2018 quoting "Dr Reddy's cracks on buzz of issues raised in EIR for Duvvada plant".

The reply is awaited.

Dr Reddy's Laboratories on November 21, 2017, informed the stock

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in